Multiple host tissues and immune cell populations

The term Multiple host tissues and immune cell populations refers to a broad physiological or anatomical distribution rather than a specific molecular target, such as a receptor, enzyme, or ion channel. In the context of pharmacology and drug discovery, a therapeutic target is defined as a discrete molecular entity whose activity is modified by a drug to produce a clinical effect (Santos et al., 2017, Nature Reviews Drug Discovery). This phrase is frequently used in scientific literature to describe the systemic reach of pathogens, such as viruses that infect various organs, or the pleiotropic effects of systemic therapies like corticosteroids (Croston, 2017, Expert Opinion on Drug Discovery). Because it encompasses a diverse array of cell types—including lymphocytes, myeloid cells, and various parenchymal tissues—it does not possess a single molecular classification or a unified mechanism of action. Consequently, it is considered an incorrect or non-specific designation for a therapeutic target, as it lacks the molecular precision necessary for modern drug development and target validation. Identifying specific receptors or signaling proteins within these tissues is the standard requirement for characterizing a druggable target.

Not applicable as this entry describes a broad physiological distribution rather than a specific molecular entity.